Over 483 million people are living with type 2 diabetes and 1.2 million are living with type 1 diabetes around the world. These numbers are steadily growing and put a strain on individuals, families, and healthcare systems.

As a healthcare professional, diabetes conferences are ways to get up-to-date about everything diabetes. They also provide great opportunities to network with diabetologists, endocrinologists, and other diabetes professionals. Join international experts, doctors, research scholars, general practitioners, student delegates and exhibitors from all over the world for the latest advances and resources for this disease.

Here on CongressHub, we bring inspiration, videos, highlights, and other content directly to you.

With over a century of diabetes care innovation and experience, Novo Nordisk is committed to driving change to improve treatment options for people living with diabetes. From developing more effective medicines to improving delivery systems, we're building on our heritage to make diabetes management simpler.

As we look to the future, we hope to bring greater flexibility and a more holistic approach to diabetes care. At diabetes conferences, we present our groundbreaking innovations, products, and science. We want to engage with healthcare professionals and provide support for their clinical practice and patients' needs. By sharing knowledge and insights, we hope we can all work together to defeat diabetes.

Defeating diabetes and other serious chronic diseases is not something we at Novo Nordisk can tackle alone. In our research, development, production and commercial operations, we work with partners who complement our own expertise.

We are always on the lookout for new opportunities with people and organizations who are interested in collaborating to change patients’ lives, together.

And so, Novo Nordisk will be at various diabetes conferences in 2023. Just as we have in other years, we are working to help accelerate scientific discovery and innovation in mutual areas of interest.